BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35730719)

  • 1. De-Novo Depression, Prophylactic Antidepressant, and Survival in Patients With Head and Neck Cancer.
    Panwar A; McGill T; Lydiatt D; Militsakh O; Lindau R; Coughlin A; Sayles H; Smith R; Lydiatt W
    Laryngoscope; 2023 Apr; 133(4):856-862. PubMed ID: 35730719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Baseline Characteristics Associated With Development of Depression Among Patients With Head and Neck Cancer: A Secondary Analysis of a Randomized Clinical Trial.
    Panwar A; Rieke K; Burke WJ; Sayles H; Lydiatt WM;
    JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1004-1010. PubMed ID: 30286230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of depression with escitalopram in patients undergoing treatment for head and neck cancer: randomized, double-blind, placebo-controlled clinical trial.
    Lydiatt WM; Bessette D; Schmid KK; Sayles H; Burke WJ
    JAMA Otolaryngol Head Neck Surg; 2013 Jul; 139(7):678-86. PubMed ID: 23788218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial of Psilocybin versus Escitalopram for Depression.
    Carhart-Harris R; Giribaldi B; Watts R; Baker-Jones M; Murphy-Beiner A; Murphy R; Martell J; Blemings A; Erritzoe D; Nutt DJ
    N Engl J Med; 2021 Apr; 384(15):1402-1411. PubMed ID: 33852780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression as a predictor of postoperative functional performance status (PFPS) and treatment adherence in head and neck cancer patients: a prospective study.
    Barber B; Dergousoff J; Nesbitt M; Mitchell N; Harris J; O'Connell D; Côté D; Biron V; Seikaly H
    J Otolaryngol Head Neck Surg; 2015 Sep; 44(1):38. PubMed ID: 26385356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study.
    Kubota A; Nakatani E; Tsukahara K; Hasegawa Y; Takemura H; Terada T; Taguchi T; Nagahara K; Nakatani H; Yoshino K; Higaki Y; Iwae S; Beppu T; Hanamure Y; Tomita K; Kohno N; Kawabata K; Teramukai S; Fujii M;
    PLoS One; 2018; 13(6):e0198391. PubMed ID: 29883463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.
    Hu YD; Xiang YT; Fang JX; Zu S; Sha S; Shi H; Ungvari GS; Correll CU; Chiu HF; Xue Y; Tian TF; Wu AS; Ma X; Wang G
    Psychol Med; 2016 Feb; 46(3):623-35. PubMed ID: 26478208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of depression in adults with long-term physical conditions.
    Kampling H; Baumeister H; Bengel J; Mittag O
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD011246. PubMed ID: 33667319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life scores as prognostic factors of overall survival in advanced head and neck cancer: analysis of a phase III randomized trial of pemetrexed plus cisplatin versus cisplatin monotherapy.
    Urba S; Gatz J; Shen W; Hossain A; Winfree K; Koustenis A; Peterson P; Cohen EE
    Oral Oncol; 2012 Aug; 48(8):723-9. PubMed ID: 22414289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
    Sung SC; Haley CL; Wisniewski SR; Fava M; Nierenberg AA; Warden D; Morris DW; Kurian BT; Trivedi MH; Rush AJ;
    J Clin Psychiatry; 2012 Jul; 73(7):967-76. PubMed ID: 22687487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy Plus Cisplatin With or Without Lapatinib for Non-Human Papillomavirus Head and Neck Carcinoma: A Phase 2 Randomized Clinical Trial.
    Wong SJ; Torres-Saavedra PA; Saba NF; Shenouda G; Bumpous JM; Wallace RE; Chung CH; El-Naggar AK; Gwede CK; Burtness B; Tennant PA; Dunlap NE; Redman R; Stokes WA; Rudra S; Mell LK; Sacco AG; Spencer SA; Nabell L; Yao M; Cury FL; Mitchell DL; Jones CU; Firat S; Contessa JN; Galloway T; Currey A; Harris J; Curran WJ; Le QT
    JAMA Oncol; 2023 Nov; 9(11):1565-1573. PubMed ID: 37768670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Association Between Computed Tomography-Defined Sarcopenia and Outcomes in Adult Patients Undergoing Radiotherapy of Curative Intent for Head and Neck Cancer: A Systematic Review.
    Findlay M; White K; Lai M; Luo D; Bauer JD
    J Acad Nutr Diet; 2020 Aug; 120(8):1330-1347.e8. PubMed ID: 32711854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial.
    Hedayati SS; Gregg LP; Carmody T; Jain N; Toups M; Rush AJ; Toto RD; Trivedi MH
    JAMA; 2017 Nov; 318(19):1876-1890. PubMed ID: 29101402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reevaluating the Efficacy and Predictability of Antidepressant Treatments: A Symptom Clustering Approach.
    Chekroud AM; Gueorguieva R; Krumholz HM; Trivedi MH; Krystal JH; McCarthy G
    JAMA Psychiatry; 2017 Apr; 74(4):370-378. PubMed ID: 28241180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manualised cognitive-behavioural therapy in treating depression in advanced cancer: the CanTalk RCT.
    Serfaty M; King M; Nazareth I; Moorey S; Aspden T; Tookman A; Mannix K; Gola A; Davis S; Wood J; Jones L
    Health Technol Assess; 2019 May; 23(19):1-106. PubMed ID: 31097078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol and cigarette consumption predict mortality in patients with head and neck cancer: a pooled analysis within the International Head and Neck Cancer Epidemiology (INHANCE) Consortium.
    Giraldi L; Leoncini E; Pastorino R; Wünsch-Filho V; de Carvalho M; Lopez R; Cadoni G; Arzani D; Petrelli L; Matsuo K; Bosetti C; La Vecchia C; Garavello W; Polesel J; Serraino D; Simonato L; Canova C; Richiardi L; Boffetta P; Hashibe M; Lee YCA; Boccia S
    Ann Oncol; 2017 Nov; 28(11):2843-2851. PubMed ID: 28945835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.
    Kessler D; Burns A; Tallon D; Lewis G; MacNeill S; Round J; Hollingworth W; Chew-Graham C; Anderson I; Campbell J; Dickens C; Macleod U; Gilbody S; Davies S; Peters TJ; Wiles N
    Health Technol Assess; 2018 Nov; 22(63):1-136. PubMed ID: 30468145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Weston J; Singh J; Marson AG
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.
    Davis AK; Barrett FS; May DG; Cosimano MP; Sepeda ND; Johnson MW; Finan PH; Griffiths RR
    JAMA Psychiatry; 2021 May; 78(5):481-489. PubMed ID: 33146667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.